"Immunotherapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection.
| Descriptor ID |
D007167
|
| MeSH Number(s) |
E02.095.465.425
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Immunotherapy".
Below are MeSH descriptors whose meaning is more specific than "Immunotherapy".
This graph shows the total number of publications written about "Immunotherapy" by people in this website by year, and whether "Immunotherapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 13 | 16 | 29 |
| 1992 | 12 | 9 | 21 |
| 1993 | 16 | 29 | 45 |
| 1994 | 24 | 19 | 43 |
| 1995 | 24 | 27 | 51 |
| 1996 | 19 | 21 | 40 |
| 1997 | 25 | 34 | 59 |
| 1998 | 31 | 34 | 65 |
| 1999 | 37 | 34 | 71 |
| 2000 | 19 | 28 | 47 |
| 2001 | 28 | 43 | 71 |
| 2002 | 136 | 156 | 292 |
| 2003 | 179 | 149 | 328 |
| 2004 | 174 | 159 | 333 |
| 2005 | 197 | 166 | 363 |
| 2006 | 192 | 165 | 357 |
| 2007 | 211 | 219 | 430 |
| 2008 | 233 | 228 | 461 |
| 2009 | 224 | 229 | 453 |
| 2010 | 305 | 207 | 512 |
| 2011 | 335 | 210 | 545 |
| 2012 | 286 | 263 | 549 |
| 2013 | 366 | 277 | 643 |
| 2014 | 444 | 327 | 771 |
| 2015 | 524 | 371 | 895 |
| 2016 | 687 | 440 | 1127 |
| 2017 | 870 | 557 | 1427 |
| 2018 | 884 | 584 | 1468 |
| 2019 | 329 | 250 | 579 |
| 2020 | 52 | 49 | 101 |
To return to the timeline, click here.
Below are the most recent publications written about "Immunotherapy" by people in Profiles.
-
Immune asynchrony in COVID-19 pathogenesis and potential immunotherapies. J Exp Med. 2020 10 05; 217(10).
-
Reduced Monocytic Human Leukocyte Antigen-DR Expression Indicates Immunosuppression in Critically Ill COVID-19 Patients. Anesth Analg. 2020 10; 131(4):993-999.
-
Potential Immunotherapeutic Targets for Hypoxia Due to COVI-Flu. Shock. 2020 10; 54(4):438-450.
-
Immune Checkpoints in Viral Infections. Viruses. 2020 09 21; 12(9).
-
COVID-19 and the newly rediscovered multidisciplinarity. Immunotherapy. 2020 10; 12(15):1101-1103.
-
Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy. Immunotherapy. 2020 10; 12(15):1139-1148.
-
Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2. mBio. 2020 09 10; 11(5).
-
COVID-19 in a patient with advanced Merkel cell carcinoma receiving immunotherapy. Immunotherapy. 2020 10; 12(15):1133-1138.
-
Advances in SARS-CoV-2: a systematic review. Eur Rev Med Pharmacol Sci. 2020 09; 24(17):9208-9215.
-
The impact of the COVID-19 pandemic on lung cancer patients. Ann Palliat Med. 2020 Sep; 9(5):3373-3378.